here it is October 30, 2016, 03:39 pm FBI to review

New Post Public Reply Private Reply Replies (1) Message Board
john1234 INSTATRADER #24103
here it is
October 30, 2016, 03:39 pm
FBI to review 650,000 emails on Weiner's laptop: report
By Jessie Hellmann

The FBI will examine roughly 650,000 emails on the laptop of former congressman Anthony Weiner to discover any related to a prior probe of Hillary Clintons use of a private server, according to the Wall Street Journal.

Metadata on the laptop suggests there may be thousands of emails sent to or from the private server Clinton used while she was secretary of state.
The probe had to wait for a court order because the emails were uncovered in an unrelated investigation of Weiner, the estranged husband of top Clinton aide Huma Abedin.

That order was delayed for reasons that remain unclear, the Journal reported on Sunday.

The review of the emails is expected to take weeks at a minimum and will determine whether the messages are worked related emails between Abedin and the State Department; how many are duplicates of emails already reviewed and whether any include classified information, according to the Journal.

FBI Director James Comey notified Congress on Friday of the discovery of such emails, resulting in outrage from Republicans and GOP nominee Donald Trump

The Clinton campaign, meanwhile, has questioned the timing of the announcement, with less than two weeks until Election Day, and pressed Comey on Sunday to release more information, even releasing a video spot aimed at addressing new questions about the probe.

Clinton campaign press secretary Brian Fallon responded to the Journal's story on Twitter Sunday.

"These are misleading leaks from the FBI and it is shameless," Fallon said.

source
http://thehill.com/blogs/ballot-box/president...top-report



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading